Terms: = Endocrine gland cancer AND MEN1, ENSG00000133895, 4221 AND Treatment
347 results:
1. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract] [Full Text] [Related]
2. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
3. Microwave ablation for recurrent primary hyperparathyroidism in four patients with multiple endocrine neoplasia type 1: a case series report.
Tan J; Zhang Y; Han X; Fan Y; Xu J; Chen G; Liu C; Xu S
Int J Hyperthermia; 2024; 41(1):2308056. PubMed ID: 38314667
[TBL] [Abstract] [Full Text] [Related]
4. Spatial profiling reveals tissue-specific neuro-immune interactions in gastroenteropancreatic neuroendocrine tumors.
Duan S; Sawyer TW; Witten BL; Song H; Else T; Merchant JL
J Pathol; 2024 Mar; 262(3):362-376. PubMed ID: 38229586
[TBL] [Abstract] [Full Text] [Related]
5. [Individualized approach for men1-associated duodenopancreatic neuroendocrine neoplasms].
Manoharan J; Albers MB; Bartsch DK
Chirurgie (Heidelb); 2024 Mar; 95(3):207-215. PubMed ID: 38180518
[TBL] [Abstract] [Full Text] [Related]
6. Management of Gastric Neuroendocrine Tumors: A Review.
Sok C; Ajay PS; Tsagkalidis V; Kooby DA; Shah MM
Ann Surg Oncol; 2024 Mar; 31(3):1509-1518. PubMed ID: 38062290
[TBL] [Abstract] [Full Text] [Related]
7. Genetic Testing in Hereditary Pituitary Tumors.
Akkuş G; Korbonits M
Arch Med Res; 2023 Dec; 54(8):102920. PubMed ID: 38007383
[TBL] [Abstract] [Full Text] [Related]
8. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
9. [Predicting the presence of
Mokrysheva NG; Eremkina AK; Miliutina AP; Salimkhanov RK; Aboishava LA; Bibik EE; Gorbacheva AM; Elfimova AR; Kovaleva EV; Popov SV; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Nov; 69(5):4-15. PubMed ID: 37968947
[TBL] [Abstract] [Full Text] [Related]
10. Integrated treatment guided by RNA-seq-based endometrial receptivity assessment for infertility complicated by men1.
Huang X; Fu J; Zhang Q; Zhao J; Yao Z; Xia Q; Tang H; Xu A; He A; Liang S; Lu S; Li Y
Front Endocrinol (Lausanne); 2023; 14():1224574. PubMed ID: 37929040
[TBL] [Abstract] [Full Text] [Related]
11. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
[TBL] [Abstract] [Full Text] [Related]
12. Ultrasound-guided microwave ablation in the treatment of recurrent primary hyperparathyroidism in a patient with men1: a case report.
Liu Z; Zhao Y; Han X; Hu X; Zhang Y; Xu L; Chen G; Liu C; Xu S
Front Endocrinol (Lausanne); 2023; 14():1175377. PubMed ID: 37795364
[TBL] [Abstract] [Full Text] [Related]
13. Imaging surveillance in multiple endocrine neoplasia type 1: Ten years of experience with somatostatin receptor positron emission tomography.
Said M; Krogh J; Feldt-Rasmussen U; Rasmussen ÅK; Kristensen TS; Rossing CM; Johannesen HH; Oturai P; Holmager P; Kjaer A; Klose M; Langer S; Knigge U; Andreassen M
J Neuroendocrinol; 2023 Aug; 35(8):e13322. PubMed ID: 37564005
[TBL] [Abstract] [Full Text] [Related]
14. Clinically Defined Mutations in
Duan S; Sheriff S; Elvis-Offiah UB; Witten BL; Sawyer TW; Sundaresan S; Cierpicki T; Grembecka J; Merchant JL
Cancer Res Commun; 2023 Jul; 3(7):1318-1334. PubMed ID: 37492626
[TBL] [Abstract] [Full Text] [Related]
15. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract] [Full Text] [Related]
16. INSULINOMA OF THE TAIL OF THE PANCREAS - A CASE REPORT.
Mucha A; Pavlevska E; Jovanoska B; Milenkovik T; Bitoska I; Jovanovska S
Georgian Med News; 2023 May; (338):104-107. PubMed ID: 37419481
[TBL] [Abstract] [Full Text] [Related]
17. Clinical profile and treatment outcomes among patients with sporadic and multiple endocrine neoplasia syndrome-related primary hyperparathyroidism.
Mathew UE; Goyal A; Upadhyay AD; Kandasamy D; Agarwal S; Sharma CK; Sharma A; Bal C; Tandon N; Jyotsna VP
Clin Endocrinol (Oxf); 2023 Nov; 99(5):449-458. PubMed ID: 37393194
[TBL] [Abstract] [Full Text] [Related]
18. Changes in diagnosis and operative treatment of insulinoma over two decades.
Wiese D; Humburg FG; Kann PH; Rinke A; Luster M; Mahnken A; Bartsch DK
Langenbecks Arch Surg; 2023 Jun; 408(1):255. PubMed ID: 37386194
[TBL] [Abstract] [Full Text] [Related]
19. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
20. Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in men1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs.
van Vliembergen ENM; Eijkelenkamp H; Valk GD; Vriens MR; Meijer GJ; Intven MPW; de Laat JM
Front Endocrinol (Lausanne); 2023; 14():994370. PubMed ID: 37305036
[TBL] [Abstract] [Full Text] [Related]
[Next]
